Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04322734 · ClinicalTrials.gov registry record
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
A clinical trial of Autism Spectrum Disorder and Epilepsy, sponsored by Southwest Autism Research & Resource Center.
- Recruiting
- Registry status
- 500
- Enrollment target
- 2
- Study locations
NCT04322734: Recruiting study of Autism Spectrum Disorder and Epilepsy, sponsored by Southwest Autism Research & Resource Center.
NCT04322734 is a study of Autism Spectrum Disorder and Epilepsy that is actively recruiting participants, run by Southwest Autism Research & Resource Center. The registered enrollment target is 500 participants, above the 133-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (276% higher). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04322734, a study of Autism Spectrum Disorder and Epilepsy, is actively recruiting participants, sponsored by Southwest Autism Research & Resource Center.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study involves up to 5 visits for a fasting blood draw, behavioral assessments, and/or questionnaires. Other samples may be collected when appropriate. This study is currently recruiting. There is no cost for visits or study-related exams.
Primary Outcome
Children with ASD will be differentiated from all other cohorts and have a specific pattern of mitochondrial dysfunction that will be different from and comparable to other groups of children in the study (e.g. mitochondrial disease without autism, typically developing, autism with mitochondrial disease, and developmental delay). It is hypothesized that these children will have a more pronounced delay in their development and will have a higher probability for poor developmental and behavioral o
Conditions Studied
Study Locations (2)
Arizona
- Southwestern Research and Resource Center - Phoenix
New York
- State University of New York, Downstate - Brooklyn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2023-12-13 |
| Est. Completion | 2028-12-31 |
What NCT04322734 shows while recruiting
NCT04322734 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 224 other Autism Spectrum Disorder trials with a reported enrollment target (276% higher).
The record links to 6 conditions, with Autism Spectrum Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT04322734 reports a single indexed study location in Arizona, New York.
Frequently Asked Questions
What is clinical trial NCT04322734 about?
NCT04322734 is a clinical study titled "Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders". The study involves up to 5 visits for a fasting blood draw, behavioral assessments, and/or questionnaires. Other samples may be collected when appropriate. This study is currently recruiting. There is no cost for visits or study-related exams.
What is the current status of trial NCT04322734?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2023-12-13. Estimated completion is 2028-12-31.
What conditions does trial NCT04322734 study?
This clinical trial studies the following conditions: Autism Spectrum Disorder, Epilepsy, Brain Tumor, Psychiatric Disorder, Mitochondrial Diseases.
Who is sponsoring clinical trial NCT04322734?
This trial is sponsored by Southwest Autism Research & Resource Center, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04322734 being conducted?
This trial has 2 study locations across Arizona, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism Spectrum Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04322734's enrollment target sits among peer trials
500 11th of 224 higher than 211 of 224 other Autism Spectrum Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism Spectrum Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design
RECRUITING · Early Phase 1
-
Cannabidiol (CBD) in Adults With ASD
RECRUITING · Phase 1
-
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
RECRUITING · NA
-
Pimavanserin for Rigid-compulsive Symptoms in Autism Spectrum Disorder
RECRUITING · Phase 2
-
Emergent Multi-Class Imitation Training
RECRUITING · NA
-
Physical Activity and Community EmPOWERment Project
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI